Citations 251

Plasma Alzheimer's disease biomarker relationships with incident abnormal amyloid PET

Alzheimer's & Dementia | February 26, 2025 | Volume: 21 | Issue: 2 | Pages: No page available

10.1002/alz.14629 | PMID 39989078

Abstract INTRODUCTION Limited data exist on the utility of plasma biomarkers to predict incident abnormal amyloid positron emission tomography (PET). In this study we evaluate the association of plasma Alzheimer's disease (AD) biomarkers with amyloid PET progression among initially amyloid PET negative (A−) individuals. METHODS We included 290 A−, cognitively unimpaired Mayo Clinic Study of Aging participants. We estimated the association of each baseline plasma biomarker with progression from A− to A+ and with rate of amyloid PET change. RESULTS Interquartile range differences in amyloid beta 42/40, percent phosphorylated tau 217 (%p‐tau217), and Amyloid Probability Score 2 were associated with 1.29 ( P = 0.09), 1.38 ( P < 0.001), and 1.20 ( P = 0.05) increases, respectively, in the hazard of progression from A− to A+ and 0.27 ( P = 0.16), 0.50 ( P = 0.007), and 0.28 ( P = 0.15) Centiloid/year increases, respectively, in annual rate of amyloid PET change. DISCUSSION Plasma %p‐tau217 may be a useful screening tool to enrich for participants with increased likelihood of progressing from normal to abnormal amyloid PET in a primary prevention trial. Highlights Plasma phosphorylated tau 217 was associated with amyloid positron emission tomography progression, negative to positive. The associations were weaker for amyloid beta 42/40 and Amyloid Probability Score 2. Age and apolipoprotein E ε4 carriership were also important predictors. These markers may be useful for enrichment of a primary prevention trial.
Quantitative Assessment of the Effect of Chronic Kidney Disease on Plasma P-Tau217 Concentrations

Neurology | January 17, 2025 | Volume: 104 | Issue: 3 | Pages: No page available

10.1212/wnl.0000000000210287 | PMID 39823562

White matter hyperintensities and TDP‐43 pathology in Alzheimer's disease

Alzheimer's & Dementia | January 17, 2025 | Volume: 21 | Issue: 2 | Pages: No page available

10.1002/alz.14516 | PMID 39821594

Abstract INTRODUCTION Greater white matter hyperintensities (WMHs) on magnetic resonance imaging (MRI) are seen with transactive response DNA‐binding protein 43 (TDP‐43) pathology in frontotemporal lobar degeneration (FTLD‐TDP). WMH associations with TDP‐43 pathology in Alzheimer's disease (AD‐TDP) remain unclear. METHODS A total of 157 participants from Mayo Clinic Rochester with autopsy‐confirmed AD, known TDP‐43 status, and antemortem fluid‐attenuated inversion recovery (FLAIR) MRI were included. Vascular risk factors were assessed. A semi‐automated WMH segmentation‐quantification process produced total and regional WMH volumes. Penalized linear regression models adjusting for age at MRI analyzed TDP‐43 associations (status and typing) with WMHs. RESULTS TDP‐43‐positive status was not associated with WMH burden overall because opposite effects were seen based on AD‐TDP typing. Despite similar antemortem vascular risk factors and postmortem vascular pathologies, AD‐TDP type‐ α showed greater total and regional WMH burden (particularly in subcortical frontotemporal and basal ganglia regions) than TDP‐43 negatives and AD‐TDP type‐ β . DISCUSSION AD‐TDP types may have different WMH pathomechanisms, with type‐ α having associations more like FTLD‐TDP than AD. Highlights In transactive response DNA‐binding protein 43 (TDP‐43) pathology in Alzheimer's disease (AD‐TDP), TDP‐43 status alone is not associated with total or regional WMH burden AD‐TDP type‐ α shows greater total, frontotemporal subcortical, and basal ganglia white matter hyperintensities (WMHs) AD‐TDP type‐ β shows less total and subcortical occipital WMHs AD‐TDP type‐ α effect on WMH burden closely mimics the effects of frontotemporal lobar degeneration with TDP‐43 (FTLD‐TDP) rather than AD Different relationships of AD‐TDP types with WMHs suggest different pathomechanisms
Association between temporal lobe cortical NODDI measures and memory function

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S2 | Pages: No page available

10.1002/alz.091698

AbstractBackgroundCortical structural changes in the temporal lobes including global and hippocampal volume loss and decrease in cortical thickness are well‐associated findings linked to cognitive decline in MCI and dementia patients. Neurite orientation dispersion and density imaging (NODDI) is a multishell diffusion MRI method enabling assessment of tissue microstructural integrity at the axonal and dendritic level. We wished to determine whether changes in temporal cortex orientation dispersion index (ODI) & neurite density index (NDI) correlate with decreases in memory function.MethodThe MCALT_ADIR122 cortical atlas was used for ROI designation. NODDI imaging was obtained on a 3T Siemens Prisma scanner with 2 mm isotropic resolution. Participants (ages 60‐95 years) were cognitively unimpaired (CU) or had mild cognitive impairment (MCI). CU & MCI subjects were enrolled in the Mayo Clinic Study of Aging (MCSA) and underwent neuropsychological testing including 3 memory tests from which a composite memory z score was calculated. A generalized additive regression model was used to estimate z scores as a smooth function of ODI, NDI and cortical thickness or volume with adjustment for age, gender, education, MCSA cycle number, WMH and intracranial volume.ResultThe Table displays demographic data. Figures 1 and 2 show the relationship of NDI and ODI measures to memory z scores across participants in individual ROIs both before and after adjustment for cortical thickness (“structural MRI”) as well as for confounds listed above. Both higher cortical thickness and higher NDI values in the hippocampus and entorhinal cortex were associated with significantly higher memory z‐scores (p<0.001) (Figure 1). Higher ODI values in addition to greater cortical thickness in temporal lobe regions, including within the hippocampus, parahippocampal gyrus, entorhinal cortex and inferior temporal gyrus, were associated with higher memory z‐scores (Figure 2). These significant associations (p <=0.01) were maintained after adjusting for cortical thickness in all these regions except entorhinal cortex for ODI.ConclusionNODDI‐derived measures of microstructural integrity (NDI & ODI) within the temporal cortex may provide information about memory decline, beyond what cortical thickness analysis provides, and may be potentially useful for monitoring therapeutic effects of AD immunotherapy in the future.
Association between temporal lobe cortical NODDI measures and memory function

Alzheimer's & Dementia | January 9, 2025 | Volume: 20 | Issue: S9 | Pages: No page available

10.1002/alz.093997

AbstractBackgroundCortical structural changes in the temporal lobes including global and hippocampal volume loss and decrease in cortical thickness are well‐associated findings linked to cognitive decline in MCI and dementia patients. Neurite orientation dispersion and density imaging (NODDI) is a multishell diffusion MRI method enabling assessment of tissue microstructural integrity at the axonal and dendritic level. We wished to determine whether changes in temporal cortex orientation dispersion index (ODI) & neurite density index (NDI) correlate with decreases in memory function.MethodThe MCALT_ADIR122 cortical atlas was used for ROI designation. NODDI imaging was obtained on a 3T Siemens Prisma scanner with 2 mm isotropic resolution. Participants (ages 60‐95 years) were cognitively unimpaired (CU) or had mild cognitive impairment (MCI). CU & MCI subjects were enrolled in the Mayo Clinic Study of Aging (MCSA) and underwent neuropsychological testing including 3 memory tests from which a composite memory z score was calculated. A generalized additive regression model was used to estimate z scores as a smooth function of ODI, NDI and cortical thickness or volume with adjustment for age, gender, education, MCSA cycle number, WMH and intracranial volume.ResultThe Table displays demographic data. Figures 1 and 2 show the relationship of NDI and ODI measures to memory z scores across participants in individual ROIs both before and after adjustment for cortical thickness (“structural MRI”) as well as for confounds listed above. Both higher cortical thickness and higher NDI values in the hippocampus and entorhinal cortex were associated with significantly higher memory z‐scores (p<0.001) (Figure 1). Higher ODI values in addition to greater cortical thickness in temporal lobe regions, including within the hippocampus, parahippocampal gyrus, entorhinal cortex and inferior temporal gyrus, were associated with higher memory z‐scores (Figure 2). These significant associations (p <=0.01) were maintained after adjusting for cortical thickness in all these regions except entorhinal cortex for ODI.ConclusionNODDI‐derived measures of microstructural integrity (NDI & ODI) within the temporal cortex may provide information about memory decline, beyond what cortical thickness analysis provides, and may be potentially useful for monitoring therapeutic effects of AD immunotherapy in the future.
Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age–related tauopathy and Alzheimer’s disease

Science Translational Medicine | July 24, 2024 | Volume: 16 | Issue: 757 | Pages: No page available

10.1126/scitranslmed.ado8076 | PMID 39047115

[ 18 F]-Flortaucipir positron emission tomography (PET) is considered a good biomarker of Alzheimer’s disease. However, it is unknown how flortaucipir is associated with the distribution of tau across brain regions and how these associations are influenced by amyloid-β. It is also unclear whether flortaucipir can detect tau in definite primary age–related tauopathy (PART). We identified 248 individuals at Mayo Clinic who had undergone [ 18 F]-flortaucipir PET during life, had died, and had undergone an autopsy, 239 cases of which also had amyloid-β PET. We assessed nonlinear relationships between flortaucipir uptake in nine medial temporal and cortical regions, Braak tau stage, and Thal amyloid-β phase using generalized additive models. We found that flortaucipir uptake was greater with increasing tau stage in all regions. Increased uptake at low tau stages in medial temporal regions was only observed in cases with a high amyloid-β phase. Flortaucipir uptake linearly increased with the amyloid-β phase in medial temporal and cortical regions. The highest flortaucipir uptake occurred with high Alzheimer’s disease neuropathologic change (ADNC) scores, followed by low-intermediate ADNC scores, then PART, with the entorhinal cortex providing the best differentiation between groups. Flortaucipir PET had limited ability to detect PART, and imaging-defined PART did not correspond with pathologically defined PART. In summary, spatial patterns of flortaucipir mirrored the histopathological tau distribution, were influenced by the amyloid-β phase, and were useful for distinguishing different ADNC scores and PART.
Relationships Between Regional Burden of Tau Neuropathology and Age at Death and Disease Duration in Patients with Progressive Supranuclear Palsy (S26.003)

Neurology | April 9, 2024 | Volume: 102 | Issue: 7_supplement_1 | Pages: No page available

10.1212/wnl.0000000000206268

Volumetric analysis of hippocampal subregions and subfields in left and right semantic dementia

Brain Communications | March 21, 2024 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/braincomms/fcae097 | PMID 38572268

Abstract Two variants of semantic dementia are recognized based on the laterality of temporal lobe involvement: a left-predominant variant associated with verbal knowledge impairment and a right-predominant variant associated with behavioural changes and non-verbal knowledge loss. This cross-sectional clinicoradiologic study aimed to assess whole hippocampal, subregion, and/or subfield volume loss in semantic dementia versus controls and across its variants. Thirty-five semantic dementia participants and 15 controls from the Neurodegenerative Research Group at Mayo Clinic who had completed 3.0-T volumetric magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography were included. Classification as left-predominant (n = 25) or right-predominant (n = 10) variant was based on temporal lobe hypometabolism. Volumes of hippocampal subregions (head, body, and tail) and subfields (parasubiculum, presubiculum, subiculum, cornu ammonis 1, cornu ammonis 3, cornu ammonis 4, dentate gyrus, molecular layer, hippocampal–amygdaloid transition area, and fimbria) were obtained using FreeSurfer 7. Subfield volumes were measured separately from head and body subregions. We fit linear mixed-effects models using log-transformed whole hippocampal/subregion/subfield volumes as dependent variables; age, sex, total intracranial volume, hemisphere and a group-by-hemisphere interaction as fixed effects; and subregion/subfield nested within hemisphere as a random effect. Significant results (P &lt; 0.05) are hereby reported. At the whole hippocampal level, the dominant (predominantly involved) hemisphere of both variants showed 23–27% smaller volumes than controls. The non-dominant (less involved) hemisphere of the right-predominant variant also showed volume loss versus controls and the left-predominant variant. At the subregional level, both variants showed 17–28% smaller dominant hemisphere head, body, and tail than controls, with the right-predominant variant also showing 8–12% smaller non-dominant hemisphere head than controls and left-predominant variant. At the subfield level, the left-predominant variant showed 12–36% smaller volumes across all dominant hemisphere subfields and 14–15% smaller non-dominant hemisphere parasubiculum, presubiculum (head and body), subiculum (head) and hippocampal–amygdaloid transition area than controls. The right-predominant variant showed 16–49% smaller volumes across all dominant hemisphere subfields and 14–22% smaller parasubiculum, presubiculum, subiculum, cornu ammonis 3, hippocampal–amygdaloid transition area (all from the head) and fimbria of non-dominant hemisphere versus controls. Comparison of dominant hemispheres showed 16–29% smaller volumes of the parasubiculum, presubiculum (head) and fimbria in the right-predominant than left-predominant variant; comparison of non-dominant hemispheres showed 12–15% smaller cornu ammonis 3, cornu ammonis 4, dentate gyrus, hippocampal–amygdaloid transition area (all from the head) and cornu ammonis 1, cornu ammonis 3 and cornu ammonis 4 (all from the body) in the right-predominant variant. All hippocampal subregion/subfield volumes are affected in semantic dementia, although some are more affected in both dominant and non-dominant hemispheres of the right-predominant than the left-predominant variant by the time of presentation. Involvement of hippocampal structures is apparently more subregion dependent than subfield dependent, indicating possible superiority of subregion volumes as disease biomarkers.
Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals

Alzheimer's & Dementia | January 24, 2024 | Volume: 20 | Issue: 3 | Pages: 2143-2154

10.1002/alz.13651 | PMID 38265198

Abstract BACKGROUND We compared the ability of several plasma biomarkers versus amyloid positron emission tomography (PET) to predict rates of memory decline among cognitively unimpaired individuals. METHODS We studied 645 Mayo Clinic Study of Aging participants. Predictor variables were age, sex, education, apolipoprotein E ( APOE ) ε 4 genotype, amyloid PET, and plasma amyloid beta (Aβ)42/40, phosphorylated tau (p‐tau)181, neurofilament light (NfL), glial fibrillary acidic protein (GFAP), and p‐tau217. The outcome was a change in a memory composite measure. RESULTS All plasma biomarkers, except NfL, were associated with mean memory decline in models with individual biomarkers. However, amyloid PET and plasma p‐tau217, along with age, were key variables independently associated with mean memory decline in models combining all predictors. Confidence intervals were narrow for estimates of population mean prediction, but person‐level prediction intervals were wide. DISCUSSION Plasma p‐tau217 and amyloid PET provide useful information about predicting rates of future cognitive decline in cognitively unimpaired individuals at the population mean level, but not at the individual person level.
Within and between‐network functional connectivity disruptions in posterior cortical atrophy and dementia with Lewy bodies

Alzheimer's & Dementia | December 25, 2023 | Volume: 19 | Issue: S17 | Pages: No page available

10.1002/alz.078935

AbstractBackgroundPosterior cortical atrophy (PCA) and dementia with Lewy bodies (DLB) show overlapping patterns of hypometabolism affecting posterior regions of the brain. Both syndromes show disruptions in functional connectivity, but it is unknown how patterns of disruption within and between networks compare between PCA and DLB.MethodThirty amyloid‐positive PCA, 27 amyloid‐positive DLB (DLB+), 24 amyloid‐negative DLB (DLB‐) patients and 30 cognitively normal amyloid‐negative (CN) individuals were recruited at Mayo Clinic, Rochester, MN, and underwent structural and resting state functional MRI. Spatially preprocessed data was analyzed using the CONN functional connectivity toolbox to explore nine networks: visual, sensorimotor, dorsal‐attention, cerebellar, frontoparietal, memory, language, salience, and default mode networks (DMN). Multivariate linear regression models corrected for multiple comparisons and adjusted for age and sex were fit to analyze within‐network connectivity (Fisher’s R‐to‐Z transformations). Between‐network connectivity was assessed with group level difference maps (two‐sample t‐test) corrected for false discovery rate at p<0.05.ResultMultivariate linear regression models showed reduced within‐network connectivity across all DMN components, sensorimotor, and dorsal‐attention networks, with trends for the visual network in PCA compared to CN. Both DLB‐ and DLB+ showed reduced within‐network connectivity for the cerebellar network, with DLB+ showing reduced connectivity in the posterior‐DMN, memory, and salience networks compared to CN. DLB‐ showed increased connectivity in dorsal‐attention and DMN, while DLB+ showing reduced connectivity in the memory network compared to PCA. Between‐network analysis showed an increase in cerebellar‐to‐sensorimotor connectivity in all three groups, with increase in cerebellar‐to‐dorsal‐attention connectivity in DLB‐ and PCA compared to CN. DLB‐ showed a decrease in posterior‐DMN‐to‐sensorimotor connectivity, while PCA showed reduced connectivity between all DMN components and dorsal‐attention‐to‐sensorimotor connectivity compared to CN. There was an increase in connectivity between all DMN components and a reduction in dorsal‐DMN‐to‐sensorimotor connectivity in both DLB‐ and DLB+ compared to PCA.ConclusionPCA was associated with connectivity disruptions across all DMN components, sensorimotor, dorsal‐attention and visual networks, while both DLB groups showed disruptions in cerebellar networks, with DLB+ showing further disruptions in posterior‐DMN, memory and salience networks. These findings suggest that both PCA and DLB have unique brain network disruptions, with amyloid status influencing connectivity in DLB.